Literature DB >> 26482744

Duchenne Muscular Dystrophy: a Survey of Perspectives on Carrier Testing and Communication Within the Family.

Brenna Hayes1, Susan Hassed1, Jae Lindsay Chaloner2, Christopher E Aston1, Carrie Guy3.   

Abstract

Carrier testing is widely available for multiple genetic conditions, and several professional organizations have created practice guidelines regarding appropriate clinical application and the testing of minors. Previous research has focused on carrier screening, predictive testing, and testing for X-linked conditions. However, family perspectives on carrier testing for X-linked lethal diseases have yet to be described. In this study, we explored communication within the family about carrier testing and the perspectives of mothers of sons with an X-linked lethal disease, Duchenne muscular dystrophy (DMD). Twenty-five mothers of sons with DMD participated in an anonymous online survey. Survey questions included multiple choice, Likert scale, and open ended, short answer questions. Analysis of the multiple choice and Likert scale questions revealed that most mothers preferred a gradual style of communication with their daughters regarding risk status. In addition, most participants reported having consulted with a genetic counselor and found it helpful. Comparisons between groups, analyzed using Fisher's exact tests, found no differences in preferred style due to mother's carrier status or having a daughter. Thematic analysis was conducted on responses to open ended questions. Themes identified included the impact of family implications, age and maturity, and a desire for autonomy regarding the decision to discuss and undergo carrier testing with at-risk daughters, particularly timing of these discussions. Implications for genetic counseling practice are discussed.

Entities:  

Keywords:  Carrier testing; Communication; Duchenne muscular dystrophy; Family perspectives; Genetic counseling; Minors; Qualitative; Thematic analysis

Mesh:

Year:  2015        PMID: 26482744     DOI: 10.1007/s10897-015-9898-5

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  27 in total

1.  Duchenne muscular dystrophy.

Authors:  W Douglas Biggar
Journal:  Pediatr Rev       Date:  2006-03

2.  Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kristin M Caspers; Natalie Street; Christopher Cunniff; Katherine D Mathews; Deborah J Fox; Soman Puzhankara; Emma Ciafaloni; Katherine A James; Yin Su
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

3.  Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors.

Authors:  Fallon R Levine; James E Coxworth; David A Stevenson; Thérèse Tuohy; Randall W Burt; Anita Y Kinney
Journal:  J Genet Couns       Date:  2010-03-02       Impact factor: 2.537

4.  Parents' communication with siblings of children affected by an inherited genetic condition.

Authors:  Gillian Plumridge; Alison Metcalfe; Jane Coad; Paramjit Gill
Journal:  J Genet Couns       Date:  2011-04-19       Impact factor: 2.537

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

Review 6.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

7.  "Family matters": a conceptual framework for genetic testing in children.

Authors:  Allyn McConkie-Rosell; Gail A Spiridigliozzi
Journal:  J Genet Couns       Date:  2004-02       Impact factor: 2.537

8.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

9.  Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy.

Authors:  Prashant K Verma; Ashwin Dalal; Balraj Mittal; Shubha R Phadke
Journal:  Indian J Hum Genet       Date:  2012-01

10.  Technical report: Ethical and policy issues in genetic testing and screening of children.

Authors:  Lainie Friedman Ross; Laine Friedman Ross; Howard M Saal; Karen L David; Rebecca R Anderson
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

View more
  4 in total

1.  Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy.

Authors:  Lauren Bogue; Holly Peay; Ann Martin; Ann Lucas; Sindhu Ramchandren
Journal:  Neuromuscul Disord       Date:  2016-09-16       Impact factor: 4.296

2.  Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence.

Authors:  Harry G Fraser; Rebecca Z Redmond; Diana F Scotcher
Journal:  J Genet Couns       Date:  2018-07-04       Impact factor: 2.537

3.  Medical Attitudes Survey for Female Dystrophinopathy Carriers in Japan.

Authors:  Michio Kobayashi; Tomoyuki Hatakeyama; Masatoshi Ishizaki; Katsuhito Adachi; Mizuki Morita; Naohiro Yonemoto; Tsuyoshi Matsumura; Itaru Toyoshima; En Kimura
Journal:  Intern Med       Date:  2018-03-09       Impact factor: 1.271

4.  Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice.

Authors:  Courtney M Studwell; Emily G Kelley; Janet S Sinsheimer; Christina G S Palmer; Kimberly LeBlanc
Journal:  J Genet Couns       Date:  2020-10-27       Impact factor: 2.537

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.